Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Novel combination treatment effective in recurrent ER-positive endometrial cancer

Written by | 20 Apr 2022

Researchers from a phase 2 study report that combination treatment with abemaciclib and letrozole shrinks or stabilizes tumors in a majority of subjects diagnosed with recurrent or persistent… read more.

Half of all women experience false positive mammograms after 10 years of annual screening

Written by | 28 Mar 2022

A study led by UC Davis Health has found that half of all women will experience at least one false positive mammogram over a decade of annual breast… read more.

AI provides accurate breast density classification

Written by | 19 Mar 2022

An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a study in Radiology: Artificial Intelligence. Breast density reflects the amount of fibroglandular… read more.

Lab results show promise for future pancreatic cancer treatment

Written by | 13 Feb 2022

University of Illinois Chicago researchers have developed a compound that may one day offer hope for pancreatic cancer treatment. A pre-clinical study of the experimental compound shows that… read more.

Researchers discover how lactic acid weakens anti-tumor defenses

Written by | 3 Feb 2022

In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our… read more.

Glucose control lowers risk of cancer in obese diabetic patients

Written by | 18 Jan 2022

Blood glucose control is key to lowering the risk of cancer in obese persons with type 2 diabetes, researchers reported on Dec. 6, 20231 in Diabetes Care. “What… read more.

Sorting cancers by ‘immune archetypes’ represents potential new approach to developing precision immunotherapies

Written by | 16 Jan 2022

Common immune microenvironments across different types of cancer. Using data from over 300 patient tumors, researchers have described 12 classes of ‘immune archetypes’ to classify cancer tumors. Their… read more.

Sloan Kettering Institute scientists design CAR T cells to activate cancer pro-drugs at the disease site

Written by | 8 Jan 2022

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.

Cancer deaths rose to 10 million worldwide in 2019

Written by | 7 Jan 2022

Recent trends also highlight global disparities in cancer burden. Cancer deaths rose to 10 million and new cases jumped to over 23 million globally in 2019, according to… read more.

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease,… read more.

Research demonstrates that cells with cancer-associated mutations overtake human tissue with age

Written by | 23 Dec 2021

It’s worth noting, in light of recently published research, that a majority of people won’t be diagnosed with cancer in their lifetimes. According to the National Cancer Institute,… read more.

New findings on bacteria that increase risk of pancreatic cancer

Written by | 12 Dec 2021

Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumours. Now for the first time, live… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.